Deutsche Bank
KZIA

Deutsche Bank’s Kazia Therapeutics KZIA Stock Holding History

Deutsche Bank’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2
Closed -$1K – 4331
2021
Q3 		$1K Hold
2
– – ﹤0.01% 4373
2021
Q2 		$1K Hold
2
– – ﹤0.01% 4563
2021
Q1 		$1K Buy
+2
New +$1.05K ﹤0.01% 4520
2020
Q1 		– Sell
-6
Closed -$1K – 4581
2019
Q4 		$1K Buy
+6
New +$1.14K ﹤0.01% 4911
2016
Q3 		– Hold
0
– – – 5063
2016
Q2 		– Hold
0
– – – 5270
2016
Q1 		– Hold
0
– – – 5252
2015
Q4 		– Hold
0
– – – 5347

Other funds holding KZIA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Deutsche Bank's KZIA Position: Q4 2021 in Review

Deutsche Bank sold out of Kazia Therapeutics (KZIA) in Q4 2021, closing a stake of 2 shares — an estimated $1K sold.

Deutsche Bank first reported a position in KZIA in Q4 2019 and held it in 4 quarters. The position peaked at $1K in Q3 2021. 10 funds tracked by Wall St. Rank hold KZIA as of Q4 2021.

  • Deutsche Bank reported no remaining Kazia Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Deutsche Bank sold 2 Kazia Therapeutics shares in Q4 2021, an estimated $1K.
  • Deutsche Bank first reported a position in Kazia Therapeutics in Q4 2019 and held it in 4 quarters.
  • Deutsche Bank's Kazia Therapeutics position peaked at $1K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.